Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Achieve Life Sciences, Inc.

Achieve Life Sciences to Participate in Upcoming Investor Conferences
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death
Exposures Death
Tickers ACHV
Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property
Tickers ACHV
Achieve Life Sciences to Participate in Two Upcoming Investor Conferences
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death
Exposures Death
Tickers ACHV
Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property
Tickers ACHV
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures COVID-19 Death Intellectual Property
Tickers ACHV
Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ACHV
Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
From Achieve Life Sciences, Inc.
Via AccessWire
Tickers ACHV
Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ACHV
Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ACHV
Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ACHV
Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death
Exposures Death Product Safety
Tickers ACHV
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Regulatory Compliance
Exposures Death Legal Product Safety
Tickers ACHV
Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Regulatory Compliance
Exposures Death Legal Product Safety
Tickers ACHV
Achieve Life Sciences Announces Proposed Underwritten Public Offering
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Regulatory Compliance
Exposures Death Legal Product Safety
Tickers ACHV
Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures COVID-19 Death Intellectual Property
Tickers ACHV
Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021
From Achieve Life Sciences, Inc.
Via AccessWire
Tickers ACHV
Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ACHV
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property Product Safety
Tickers ACHV
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.